Core Points - Moss Genomics Inc. has completed a non-brokered private placement of 555,555 common shares at a price of $0.18 per share, raising gross proceeds of $100,000 [1] - The company also issued 5,164,213 common shares at a deemed price of $0.18 per share as part of asset purchase agreements, acquiring approximately 224.7523 ETH at an average price of $3,833 per ETH, totaling $966,435 [2] - Following these transactions, Moss has a total of 63,414,545 common shares issued and outstanding [3] - An Annual and Special General Meeting is scheduled for November 13, 2025, to be conducted virtually [4] Company Overview - Moss Genomics is focused on developing a secure platform for genomic data, allowing individuals to manage their DNA and participate in research monetization [5] - The company utilizes Ethereum-based infrastructure, with ETH funding development, DNA sequencing services, and future operations [5] - The mission of Moss Genomics is to advance decentralized and privacy-preserving genomics through practical applications in health, identity, and research [5]